Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]

Overview of attention for article published in OncoTargets and therapy, September 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,717 followers.

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: ... https://t.co/MJF05Bpflr

New article: Erratum: Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]. https://t.co/9h6Ix8JsC1 #MCL #lymsm #hematology https://t.co/qkqrk2jfBZ